Global Antibody Drug Conjugates Contract Manufacturing Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 103

Published Date: 13 Apr 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Antibody Drug Conjugates Contract Manufacturing market size was valued at USD 2909.1 million in 2022 and is forecast to a readjusted size of USD 9320.3 million by 2029 with a CAGR of 18.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Key global companies of Antibody Drug Conjugates Contract Manufacturing (ADC) include Lonza, Merck, Recipharm, Thermo Fisher, AbbVie, Piramal Pharma Solutions, Catalent, Sterling Pharma Solutions and Curia. The top three players are Lonza, Merck and Recipharm, which together account for about 50% of the global market share. The largest player is Lonza Group. From the production side, the global players are mainly concentrated in North America and Europe. North America accounts for about 35% of the global market share. In terms of type, IgG1 dominates the global antibody drug conjugate contract manufacturing market. In terms of application, solid tumor applications account for more than half of the market.

ADCs are mainly composed of three parts: antibodies, linkers, and cytotoxic loads. They are a type of bioactive cytotoxic drugs that are linked to monoclonal antibodies through chemical bonds and use monoclonal antibodies as carriers to target and transport cytotoxic drugs to target cells. Complex that works. The design concept of ADC was first proposed by Paul Ehrlich in the early 20th century. In 2000, the U.S. Food and Drug Administration (FDA) approved the first ADC drug, Mylotarg® (gemtuzumab ozogamicin), for the treatment of acute myeloid myelopathy in adults. Leukemic cell lines, marking the beginning of the era of ADC-targeted cancer therapy.

This report is a detailed and comprehensive analysis for global Antibody Drug Conjugates Contract Manufacturing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Antibody Drug Conjugates Contract Manufacturing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Antibody Drug Conjugates Contract Manufacturing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Antibody Drug Conjugates Contract Manufacturing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Antibody Drug Conjugates Contract Manufacturing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antibody Drug Conjugates Contract Manufacturing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antibody Drug Conjugates Contract Manufacturing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza Group, Merck KGaA, Recipharm, Thermo Fisher Scientific and Abbvie, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Antibody Drug Conjugates Contract Manufacturing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    IgG1
    IgG4

Market segment by Application
    Solid Tumors
    Hematological Malignancies

Market segment by players, this report covers
    Lonza Group
    Merck KGaA
    Recipharm
    Thermo Fisher Scientific
    Abbvie
    Piramal Pharma Solutions
    Catalent
    Sterling Pharma Solutions
    Curia
    Novasep
    Ajinomoto Bio-Pharma Services
    BSP Pharmaceuticals
    Cerbios-Pharma
    Goodwin Biotechnology

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Antibody Drug Conjugates Contract Manufacturing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antibody Drug Conjugates Contract Manufacturing, with revenue, gross margin and global market share of Antibody Drug Conjugates Contract Manufacturing from 2018 to 2023.
Chapter 3, the Antibody Drug Conjugates Contract Manufacturing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Antibody Drug Conjugates Contract Manufacturing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Antibody Drug Conjugates Contract Manufacturing.
Chapter 13, to describe Antibody Drug Conjugates Contract Manufacturing research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Antibody Drug Conjugates Contract Manufacturing
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Antibody Drug Conjugates Contract Manufacturing by Type
        1.3.1 Overview: Global Antibody Drug Conjugates Contract Manufacturing Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Type in 2022
        1.3.3 IgG1
        1.3.4 IgG4
    1.4 Global Antibody Drug Conjugates Contract Manufacturing Market by Application
        1.4.1 Overview: Global Antibody Drug Conjugates Contract Manufacturing Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Solid Tumors
        1.4.3 Hematological Malignancies
    1.5 Global Antibody Drug Conjugates Contract Manufacturing Market Size & Forecast
    1.6 Global Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast by Region
        1.6.1 Global Antibody Drug Conjugates Contract Manufacturing Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Antibody Drug Conjugates Contract Manufacturing Market Size by Region, (2018-2029)
        1.6.3 North America Antibody Drug Conjugates Contract Manufacturing Market Size and Prospect (2018-2029)
        1.6.4 Europe Antibody Drug Conjugates Contract Manufacturing Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market Size and Prospect (2018-2029)
        1.6.6 South America Antibody Drug Conjugates Contract Manufacturing Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Antibody Drug Conjugates Contract Manufacturing Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Lonza Group
        2.1.1 Lonza Group Details
        2.1.2 Lonza Group Major Business
        2.1.3 Lonza Group Antibody Drug Conjugates Contract Manufacturing Product and Solutions
        2.1.4 Lonza Group Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Lonza Group Recent Developments and Future Plans
    2.2 Merck KGaA
        2.2.1 Merck KGaA Details
        2.2.2 Merck KGaA Major Business
        2.2.3 Merck KGaA Antibody Drug Conjugates Contract Manufacturing Product and Solutions
        2.2.4 Merck KGaA Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Merck KGaA Recent Developments and Future Plans
    2.3 Recipharm
        2.3.1 Recipharm Details
        2.3.2 Recipharm Major Business
        2.3.3 Recipharm Antibody Drug Conjugates Contract Manufacturing Product and Solutions
        2.3.4 Recipharm Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Recipharm Recent Developments and Future Plans
    2.4 Thermo Fisher Scientific
        2.4.1 Thermo Fisher Scientific Details
        2.4.2 Thermo Fisher Scientific Major Business
        2.4.3 Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Product and Solutions
        2.4.4 Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
    2.5 Abbvie
        2.5.1 Abbvie Details
        2.5.2 Abbvie Major Business
        2.5.3 Abbvie Antibody Drug Conjugates Contract Manufacturing Product and Solutions
        2.5.4 Abbvie Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Abbvie Recent Developments and Future Plans
    2.6 Piramal Pharma Solutions
        2.6.1 Piramal Pharma Solutions Details
        2.6.2 Piramal Pharma Solutions Major Business
        2.6.3 Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product and Solutions
        2.6.4 Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Piramal Pharma Solutions Recent Developments and Future Plans
    2.7 Catalent
        2.7.1 Catalent Details
        2.7.2 Catalent Major Business
        2.7.3 Catalent Antibody Drug Conjugates Contract Manufacturing Product and Solutions
        2.7.4 Catalent Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Catalent Recent Developments and Future Plans
    2.8 Sterling Pharma Solutions
        2.8.1 Sterling Pharma Solutions Details
        2.8.2 Sterling Pharma Solutions Major Business
        2.8.3 Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product and Solutions
        2.8.4 Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Sterling Pharma Solutions Recent Developments and Future Plans
    2.9 Curia
        2.9.1 Curia Details
        2.9.2 Curia Major Business
        2.9.3 Curia Antibody Drug Conjugates Contract Manufacturing Product and Solutions
        2.9.4 Curia Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Curia Recent Developments and Future Plans
    2.10 Novasep
        2.10.1 Novasep Details
        2.10.2 Novasep Major Business
        2.10.3 Novasep Antibody Drug Conjugates Contract Manufacturing Product and Solutions
        2.10.4 Novasep Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Novasep Recent Developments and Future Plans
    2.11 Ajinomoto Bio-Pharma Services
        2.11.1 Ajinomoto Bio-Pharma Services Details
        2.11.2 Ajinomoto Bio-Pharma Services Major Business
        2.11.3 Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Product and Solutions
        2.11.4 Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Ajinomoto Bio-Pharma Services Recent Developments and Future Plans
    2.12 BSP Pharmaceuticals
        2.12.1 BSP Pharmaceuticals Details
        2.12.2 BSP Pharmaceuticals Major Business
        2.12.3 BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Product and Solutions
        2.12.4 BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 BSP Pharmaceuticals Recent Developments and Future Plans
    2.13 Cerbios-Pharma
        2.13.1 Cerbios-Pharma Details
        2.13.2 Cerbios-Pharma Major Business
        2.13.3 Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Product and Solutions
        2.13.4 Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Cerbios-Pharma Recent Developments and Future Plans
    2.14 Goodwin Biotechnology
        2.14.1 Goodwin Biotechnology Details
        2.14.2 Goodwin Biotechnology Major Business
        2.14.3 Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Product and Solutions
        2.14.4 Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Goodwin Biotechnology Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Antibody Drug Conjugates Contract Manufacturing Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Antibody Drug Conjugates Contract Manufacturing by Company Revenue
        3.2.2 Top 3 Antibody Drug Conjugates Contract Manufacturing Players Market Share in 2022
        3.2.3 Top 6 Antibody Drug Conjugates Contract Manufacturing Players Market Share in 2022
    3.3 Antibody Drug Conjugates Contract Manufacturing Market: Overall Company Footprint Analysis
        3.3.1 Antibody Drug Conjugates Contract Manufacturing Market: Region Footprint
        3.3.2 Antibody Drug Conjugates Contract Manufacturing Market: Company Product Type Footprint
        3.3.3 Antibody Drug Conjugates Contract Manufacturing Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Antibody Drug Conjugates Contract Manufacturing Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Antibody Drug Conjugates Contract Manufacturing Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Application (2018-2023)
    5.2 Global Antibody Drug Conjugates Contract Manufacturing Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2018-2029)
    6.2 North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2018-2029)
    6.3 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country
        6.3.1 North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2018-2029)
        6.3.2 United States Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
        6.3.3 Canada Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
        6.3.4 Mexico Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2018-2029)
    7.2 Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2018-2029)
    7.3 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country
        7.3.1 Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2018-2029)
        7.3.2 Germany Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
        7.3.3 France Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
        7.3.5 Russia Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
        7.3.6 Italy Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market Size by Region
        8.3.1 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Region (2018-2029)
        8.3.2 China Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
        8.3.3 Japan Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
        8.3.4 South Korea Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
        8.3.5 India Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
        8.3.7 Australia Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2018-2029)
    9.2 South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2018-2029)
    9.3 South America Antibody Drug Conjugates Contract Manufacturing Market Size by Country
        9.3.1 South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2018-2029)
        9.3.2 Brazil Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
        9.3.3 Argentina Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size by Country
        10.3.1 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2018-2029)
        10.3.2 Turkey Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)
        10.3.4 UAE Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Antibody Drug Conjugates Contract Manufacturing Market Drivers
    11.2 Antibody Drug Conjugates Contract Manufacturing Market Restraints
    11.3 Antibody Drug Conjugates Contract Manufacturing Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Antibody Drug Conjugates Contract Manufacturing Industry Chain
    12.2 Antibody Drug Conjugates Contract Manufacturing Upstream Analysis
    12.3 Antibody Drug Conjugates Contract Manufacturing Midstream Analysis
    12.4 Antibody Drug Conjugates Contract Manufacturing Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Lonza Group Company Information, Head Office, and Major Competitors
    Table 6. Lonza Group Major Business
    Table 7. Lonza Group Antibody Drug Conjugates Contract Manufacturing Product and Solutions
    Table 8. Lonza Group Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Lonza Group Recent Developments and Future Plans
    Table 10. Merck KGaA Company Information, Head Office, and Major Competitors
    Table 11. Merck KGaA Major Business
    Table 12. Merck KGaA Antibody Drug Conjugates Contract Manufacturing Product and Solutions
    Table 13. Merck KGaA Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Merck KGaA Recent Developments and Future Plans
    Table 15. Recipharm Company Information, Head Office, and Major Competitors
    Table 16. Recipharm Major Business
    Table 17. Recipharm Antibody Drug Conjugates Contract Manufacturing Product and Solutions
    Table 18. Recipharm Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Recipharm Recent Developments and Future Plans
    Table 20. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
    Table 21. Thermo Fisher Scientific Major Business
    Table 22. Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Product and Solutions
    Table 23. Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Thermo Fisher Scientific Recent Developments and Future Plans
    Table 25. Abbvie Company Information, Head Office, and Major Competitors
    Table 26. Abbvie Major Business
    Table 27. Abbvie Antibody Drug Conjugates Contract Manufacturing Product and Solutions
    Table 28. Abbvie Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Abbvie Recent Developments and Future Plans
    Table 30. Piramal Pharma Solutions Company Information, Head Office, and Major Competitors
    Table 31. Piramal Pharma Solutions Major Business
    Table 32. Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product and Solutions
    Table 33. Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Piramal Pharma Solutions Recent Developments and Future Plans
    Table 35. Catalent Company Information, Head Office, and Major Competitors
    Table 36. Catalent Major Business
    Table 37. Catalent Antibody Drug Conjugates Contract Manufacturing Product and Solutions
    Table 38. Catalent Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Catalent Recent Developments and Future Plans
    Table 40. Sterling Pharma Solutions Company Information, Head Office, and Major Competitors
    Table 41. Sterling Pharma Solutions Major Business
    Table 42. Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product and Solutions
    Table 43. Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Sterling Pharma Solutions Recent Developments and Future Plans
    Table 45. Curia Company Information, Head Office, and Major Competitors
    Table 46. Curia Major Business
    Table 47. Curia Antibody Drug Conjugates Contract Manufacturing Product and Solutions
    Table 48. Curia Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Curia Recent Developments and Future Plans
    Table 50. Novasep Company Information, Head Office, and Major Competitors
    Table 51. Novasep Major Business
    Table 52. Novasep Antibody Drug Conjugates Contract Manufacturing Product and Solutions
    Table 53. Novasep Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Novasep Recent Developments and Future Plans
    Table 55. Ajinomoto Bio-Pharma Services Company Information, Head Office, and Major Competitors
    Table 56. Ajinomoto Bio-Pharma Services Major Business
    Table 57. Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Product and Solutions
    Table 58. Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Ajinomoto Bio-Pharma Services Recent Developments and Future Plans
    Table 60. BSP Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 61. BSP Pharmaceuticals Major Business
    Table 62. BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Product and Solutions
    Table 63. BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. BSP Pharmaceuticals Recent Developments and Future Plans
    Table 65. Cerbios-Pharma Company Information, Head Office, and Major Competitors
    Table 66. Cerbios-Pharma Major Business
    Table 67. Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Product and Solutions
    Table 68. Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Cerbios-Pharma Recent Developments and Future Plans
    Table 70. Goodwin Biotechnology Company Information, Head Office, and Major Competitors
    Table 71. Goodwin Biotechnology Major Business
    Table 72. Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Product and Solutions
    Table 73. Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. Goodwin Biotechnology Recent Developments and Future Plans
    Table 75. Global Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million) by Players (2018-2023)
    Table 76. Global Antibody Drug Conjugates Contract Manufacturing Revenue Share by Players (2018-2023)
    Table 77. Breakdown of Antibody Drug Conjugates Contract Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 78. Market Position of Players in Antibody Drug Conjugates Contract Manufacturing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 79. Head Office of Key Antibody Drug Conjugates Contract Manufacturing Players
    Table 80. Antibody Drug Conjugates Contract Manufacturing Market: Company Product Type Footprint
    Table 81. Antibody Drug Conjugates Contract Manufacturing Market: Company Product Application Footprint
    Table 82. Antibody Drug Conjugates Contract Manufacturing New Market Entrants and Barriers to Market Entry
    Table 83. Antibody Drug Conjugates Contract Manufacturing Mergers, Acquisition, Agreements, and Collaborations
    Table 84. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value (USD Million) by Type (2018-2023)
    Table 85. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Share by Type (2018-2023)
    Table 86. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Forecast by Type (2024-2029)
    Table 87. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2018-2023)
    Table 88. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Forecast by Application (2024-2029)
    Table 89. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
    Table 90. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
    Table 91. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
    Table 92. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
    Table 93. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
    Table 94. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
    Table 95. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
    Table 96. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
    Table 97. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
    Table 98. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
    Table 99. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
    Table 100. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
    Table 101. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
    Table 102. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
    Table 103. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
    Table 104. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
    Table 105. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Region (2018-2023) & (USD Million)
    Table 106. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Region (2024-2029) & (USD Million)
    Table 107. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
    Table 108. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
    Table 109. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
    Table 110. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
    Table 111. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
    Table 112. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
    Table 113. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
    Table 114. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
    Table 115. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
    Table 116. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
    Table 117. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
    Table 118. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
    Table 119. Antibody Drug Conjugates Contract Manufacturing Raw Material
    Table 120. Key Suppliers of Antibody Drug Conjugates Contract Manufacturing Raw Materials
List of Figures
    Figure 1. Antibody Drug Conjugates Contract Manufacturing Picture
    Figure 2. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Type in 2022
    Figure 4. IgG1
    Figure 5. IgG4
    Figure 6. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 7. Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Application in 2022
    Figure 8. Solid Tumors Picture
    Figure 9. Hematological Malignancies Picture
    Figure 10. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 11. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 12. Global Market Antibody Drug Conjugates Contract Manufacturing Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 13. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Region (2018-2029)
    Figure 14. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Region in 2022
    Figure 15. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 16. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 17. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 18. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 19. Middle East and Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 20. Global Antibody Drug Conjugates Contract Manufacturing Revenue Share by Players in 2022
    Figure 21. Antibody Drug Conjugates Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 22. Global Top 3 Players Antibody Drug Conjugates Contract Manufacturing Market Share in 2022
    Figure 23. Global Top 6 Players Antibody Drug Conjugates Contract Manufacturing Market Share in 2022
    Figure 24. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Share by Type (2018-2023)
    Figure 25. Global Antibody Drug Conjugates Contract Manufacturing Market Share Forecast by Type (2024-2029)
    Figure 26. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Share by Application (2018-2023)
    Figure 27. Global Antibody Drug Conjugates Contract Manufacturing Market Share Forecast by Application (2024-2029)
    Figure 28. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
    Figure 29. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
    Figure 30. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Country (2018-2029)
    Figure 31. United States Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 32. Canada Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 33. Mexico Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 34. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
    Figure 35. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
    Figure 36. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Country (2018-2029)
    Figure 37. Germany Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 38. France Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 39. United Kingdom Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 40. Russia Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 41. Italy Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 42. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
    Figure 43. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
    Figure 44. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Region (2018-2029)
    Figure 45. China Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 46. Japan Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 47. South Korea Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 48. India Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 49. Southeast Asia Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 50. Australia Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 51. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
    Figure 52. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
    Figure 53. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Country (2018-2029)
    Figure 54. Brazil Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 55. Argentina Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 56. Middle East and Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
    Figure 57. Middle East and Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
    Figure 58. Middle East and Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Country (2018-2029)
    Figure 59. Turkey Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 60. Saudi Arabia Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 61. UAE Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 62. Antibody Drug Conjugates Contract Manufacturing Market Drivers
    Figure 63. Antibody Drug Conjugates Contract Manufacturing Market Restraints
    Figure 64. Antibody Drug Conjugates Contract Manufacturing Market Trends
    Figure 65. Porters Five Forces Analysis
    Figure 66. Manufacturing Cost Structure Analysis of Antibody Drug Conjugates Contract Manufacturing in 2022
    Figure 67. Manufacturing Process Analysis of Antibody Drug Conjugates Contract Manufacturing
    Figure 68. Antibody Drug Conjugates Contract Manufacturing Industrial Chain
    Figure 69. Methodology
    Figure 70. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Antibody Drug Conjugates Contract Manufacturing Supply, Demand and Key Producers, 2023-2029

Global Antibody Drug Conjugates Contract Manufacturing Supply, Demand and Key Producers, 2023-2029

date 13 Apr 2023

date Medical Care

The global Antibody Drug Conjugates Contract Manufacturing market size is expected to reach $ 9320.3 million by 2029, rising at a market growth of 18.1% CAGR during the forecast period (2023-2029).

Global Antibody Drug Conjugates Contract Manufacturing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Antibody Drug Conjugates Contract Manufacturing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Antibody Drug Conjugates Contract Manufacturing market size was valued at USD 2909.1 million in 2023 and is forecast to a readjusted size of USD 9320.3 million by 2030 with a CAGR of 18.1% during review period.

Global Antibody Drug Conjugates Contract Manufacturing Supply, Demand and Key Producers, 2024-2030

Global Antibody Drug Conjugates Contract Manufacturing Supply, Demand and Key Producers, 2024-2030

date 02 Apr 2024

date Medical Care

The global Antibody Drug Conjugates Contract Manufacturing market size is expected to reach $ 9320.3 million by 2030, rising at a market growth of 18.1% CAGR during the forecast period (2024-2030).

Product Tags

Antibody Drug Conjugates Contract Manufacturing

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>